Serum and synovial fluid concentrations of keratan sulfate and hyaluronan in dogs with induced stifle joint osteoarthritis following cranial cruciate ligament transection

American Journal of Veterinary Research

Volumn 67, Issue 3, 2006, Pages 429-432

  Budsberg, Steven C ^a   Lenz, Mary Ellen ^b   Thonar, Eugene J M A ^b  

^a UNIVERSITY OF GEORGIA   (United States)

^b RUSH MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; HYALURONIC ACID; KERATAN SULFATE; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD ANALYSIS; BLOOD LEVEL; CARBOHYDRATE ANALYSIS; CONTROLLED STUDY; DILUTION; DOG DISEASE; HINDLIMB; KNEE CRUCIATE LIGAMENT; KNEE OSTEOARTHRITIS; LIGAMENT SURGERY; NONHUMAN; POSTOPERATIVE PERIOD; REFERENCE VALUE; SYNOVIAL FLUID LEVEL; ANIMAL; ANIMAL DISEASE; BLOOD; CLINICAL TRIAL; DOG; METABOLISM; OSTEOARTHRITIS; SYNOVIAL FLUID;

ANIMALIA; CANIS FAMILIARIS;

ANIMALS; DOG DISEASES; DOGS; HINDLIMB; HYALURONIC ACID; KERATAN SULFATE; OSTEOARTHRITIS; SYNOVIAL FLUID;

EID: 33646361839     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.67.3.429     Document Type: Article

References (30)

1. Kraus VB, Huebner JL, Fink C, et al. Urea as a passive transport marker for arthritis biomarker studies. Arthritis Rheum 2002;46:420-427.
2. Robion FC, Doize B, Boure L, et al. Use of synovial fluid markers of cartilage synthesis and turnover to study effects of repeated intra-articular administration of methylprednisolone acetate on articular cartilage in vivo. J Orthop Res 2001;19:250-258.
3. Myers SL, Brandt KD. Effects of synovial fluid hyaluronan concentration and molecular size on clearance of protein from the canine knee. J Rheumatol 1995;22:1732-1739.
4. Myers SL, Brandt KD, Eilam O. Even low-grade synovitis significantly accelerates the clearance of protein from the canine knee. Implications for measurement of synovial fluid "markers" of osteoarthritis. Arthritis Rheum 1995;38:1085-1091.
5. Myers SL, Brandt KD, Albrecht ME. Synovial fluid glycosaminoglycan concentration does not correlate with severity of chondropathy or predict progression of osteoarthritis in a canine cruciate deficiency model. J Rheumatol 2000;27:753-763.
6. Manicourt DH, Altman RD, Williams JM, et al. Treatment with calcitonin suppresses the responses of bone, cartilage, and synovium in the early stages of canine experimental osteoarthritis and significantly reduces the severity of the cartilage lesions. Arthritis Rheum 1999;42:1159-1167.
7. Manicourt DH, Cornu O, Lenz ME, et al. Rapid and sustained rise in the serum level of hyaluronan after anterior cruciate ligament transection in the dog knee joint. J Rheumatol 1995;22:262-269.
8. Leipold HR, Goldberg RL, Lust G. Canine serum keratan sulfate and hyaluronate concentrations. Relationship to age and osteoarthritis. Arthritis Rheum 1989;32:312-321.
9. Brandt KD, Thonar EJ. Lack of association between serum keratan sulfate concentrations and cartilage changes of osteoarthritis after transection of the anterior cruciate ligament in the dog. Arthritis Rheum 1989;32:647-651.
10. Manicourt DH, Lenz ME, Thonar EJ. Levels of serum keratan sulfate rise rapidly and remain elevated following anterior cruciate ligament transection in the dog. J Rheumatol 1991;18:1872-1876.
11. Ratcliffe A, Billingham ME, Saed-Nejad F, et al. Increased release of matrix components from articular cartilage in experimental canine osteoarthritis. J Orthop Res 1992;10:350-358.
12. Ratcliffe A, Beauvais PJ, Saed-Nejad F. Differential levels of synovial fluid aggrecan aggregate components in experimental osteoarthritis and joint disease. J Orthop Res 1994;12:464-473.
13. Arican M, Carter SD, Bennett D, et al. Measurement of glycosaminoglycans and keratan sulfate in canine arthropathies. Res Vet Sci 1994;56:290-297.
14. Innes J, Sharif M, Barr A. Relations between biochemical markers of osteoarthritis and other disease parameters in a population of dogs with naturally acquired osteoarthritis of the genual joint. Am J Vet Res 1998;59:1530-1536.
15. Innes JF, Sharif M, Barr ARS. Changes in concentrations of biochemical markers of osteoarthritis following surgical repair of ruptured cranial cruciate ligaments in dogs. Am J Vet Res 1999;60:1164-1168.
16. Lindhorst E, Vail TP, Guilak F, et al. Longitudinal characterization of synovial fluid biomarkers in the canine menisectomy model of osteoarthritis. J Orthop Res 2000;18:269-280.
17. Smith GN, Mickler EA, Myers SL, et al. Effect of intraarticular hyaluronan injection on synovial fluid hyaluronan in the early stage of canine post-traumatic osteoarthritis. J Rheumatol 2001;28:1341-1346.
18. Hegemann N, Kohn B, Brunnberg L, et al. Biomarkers of joint tissue metabolism in canine osteoarthritic and arthritic joint disorders. Osteoarthritis Cartilage 2002;10:714-721.
19. Chu Q, Lopez M, Hayashi K, et al. Elevation of a collagenase generated type II collagen neoepitope and proteoglycan epitopes in synovial fluid following induction of joint instability in the dog. Osteoarthritis Cartilage 2002;10:662-669.
20. Johnson KA, Hulse DA, Hart RC, et al. Effects of an orally administered mixture of chondroitin sulfate, glucosamine hydrochloride and manganese ascorbate on synovial fluid chondroitin sulfate 3B3 and 7D4 epitope in a canine cruciate ligament transaction model of osteoarthritis. Osteoarthritis Cartilage 2001;9:14-21.
21. Thonar EJ, Masuda K, Hauselmann HJ, et al. Keratan sulfate in body fluids in joint disease. Acta Orthop Scand Suppl 1995;266:103-106.
22. Thonar EJ, Masuda K, Lenz ME, et al. Serum markers of systemic disease processes in osteoarthritis. J Rheumatol Suppl 1995;43:68-70.
23. Sharif M, Osborne DJ, Meadows K, eL al. The relevance of chondroitin and keratan sulphate markers in normal and arthritic synovial fluid. Br J Rheumatol 1996;35:951-957.
24. Sharif M, George C, Dieppe PA. Correlation between synoival fluid markers of cartilage and bone turnover and scintigraphic scan abnormalities in osteoarthritis on the knee. Arthritis Rheum 1995;38:78-81.
25. Thonar EJ. Molecular markers of metabolic changes in osteoarthritis. Osteoarthritis Cartilage 1999;7:338-339.
26. Sharif M, George E, Shepstone L, et al. Serum hyaluronic acid level as a predictor of disease progression in osteoarthritis of the knee. Arthritis Rheum 1995;38:760-767.
27. Roos H, Dahlberg L, Hoerrner LA, et al, Markers of cartilage matrix metabolism in human joint fluid and serum: the effect of exercise. Osteoarthritis Cartilage 1995;3:7-14.
28. Thonar EJ-MA, Lenz ME, Klintworth GK, et al. Quantification of keratan sulfate in blood as a marker of cartilage catabolism. Arthritis Rheum 1985;28:1367-1376.
29. Li X-Q, Thonar EJ-MA, Knudson W. Accumulation of hyaluronate in human lung carcinoma as measured by a new hyaluronate ELISA. Connect Tissue Res 1989;19:243-253.
30. Hazell PK, Dent C, Fairclough JA, et al. Changes in glycosaminoglycan epitope levels in knee joint fluid following injury. Arthritis Rheum 1995;38:953-959.